Stock Scorecard



Stock Summary for CVS Health Corp (CVS) - $78.88 as of 4/9/2026 5:41:40 PM EST

Total Score

11 out of 30

Safety Score

57 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for CVS

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for CVS

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for CVS

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for CVS

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for CVS (57 out of 100)

Stock Price Rating (Max of 10) 9
Historical Stock Price Rating (Max of 10) 9
Stock Price Trend (Max of 10) 0
Book Value (Max of 10) 9
Book Value to Price (Max of 10) 1
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 5
Dividend Yield Percentage (Max of 10) 6
Operating Margin (Max of 10) 1
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 2
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for CVS

Douglas Lane & Associates LLC Cuts Holdings in CVS Health Corporation $CVS 4/10/2026 8:19:00 AM
Flagship Capital Management Inc. Invests $2.16 Million in CVS Health Corporation $CVS 4/10/2026 8:07:00 AM
Jim Cramer Says “CVS Is Real” 4/10/2026 6:15:00 AM
Baxter Launches Pilot Program for Therapy Animals in Healthcare Settings 4/9/2026 11:37:00 PM
CVS Health, US Seek Tax-Refund Suit Stay Pending Deal Approval 4/9/2026 11:07:00 PM
CVS Health, US Seek Tax-Refund Suit Stay Pending Deal Approval 4/9/2026 11:07:00 PM
Aetna Better Health® of Virginia opens new community resource center in Roanoke 4/9/2026 2:07:00 PM
CVS Health Corporation $CVS Shares Sold by Yousif Capital Management LLC 4/8/2026 12:37:00 PM
Mail Order Pharmacy Market to Get an Explosive Growth | CVS Health 4/8/2026 12:25:00 PM
Aetna Provider Survey Reveals Optimism and Opportunities to Simplify Health Care 4/8/2026 10:37:00 AM

Financial Details for CVS

Company Overview

Ticker CVS
Company Name CVS Health Corp
Country USA
Description CVS Health (previously CVS Corporation and CVS Caremark Corporation) is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island.
Sector Name HEALTHCARE
Industry Name HEALTHCARE PLANS
Most Recent Quarter 12/31/2025
Next Earnings Date 5/7/2026

Stock Price History

Last Day Price 78.88
Price 4 Years Ago 82.46
Last Day Price Updated 4/9/2026 5:41:40 PM EST
Last Day Volume 6,758,554
Average Daily Volume 7,874,841
52-Week High 84.46
52-Week Low 56.79
Last Price to 52 Week Low 38.90%

Valuation Measures

Trailing PE 56.27
Industry PE 25.71
Sector PE 116.07
5-Year Average PE 7.46
Free Cash Flow Ratio 11.88
Industry Free Cash Flow Ratio 8.79
Sector Free Cash Flow Ratio 26.96
Current Ratio Most Recent Quarter 0.84
Total Cash Per Share 6.64
Book Value Per Share Most Recent Quarter 59.18
Price to Book Ratio 1.24
Industry Price to Book Ratio 1.88
Sector Price to Book Ratio 19.97
Price to Sales Ratio Twelve Trailing Months 0.25
Industry Price to Sales Ratio Twelve Trailing Months 0.43
Sector Price to Sales Ratio Twelve Trailing Months 24.62
Analyst Buy Ratings 18
Analyst Strong Buy Ratings 7

Share Statistics

Total Shares Outstanding 1,281,604,000
Market Capitalization 101,092,923,520
Institutional Ownership 90.18%

Dividends

Ex-Dividend Date 4/23/2026
Previous Dividend Amount 0.6650
Current Dividend Amount 0.6650
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 2.66
Trailing Annual Dividend Yield 3.62%
Forward Annual Dividend Rate 2.66
Forward Annual Dividend Yield 3.62%
5-Year Dividend Payments Count 21
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 4.86%
All-Time Dividend Growth Rate Percentage 6.93%
Dividend Payout Ratio 191.37%

Income Statement

Quarterly Earnings Growth YOY 76.60%
Annual Earnings Growth -61.68%
Reported EPS 12 Trailing Months 1.39
Reported EPS Past Year 0.00
Reported EPS Prior Year 6.75
Net Income Twelve Trailing Months 1,768,000,000
Net Income Past Year 1,768,000,000
Net Income Prior Year 4,614,000,000
Quarterly Revenue Growth YOY 8.40%
5-Year Revenue Growth 8.39%
Operating Margin Twelve Trailing Months 1.57%

Balance Sheet

Total Cash Most Recent Quarter 8,512,000,000
Total Cash Past Year 8,512,000,000
Total Cash Prior Year 8,586,000,000
Net Cash Position Most Recent Quarter -51,990,000,000
Net Cash Position Past Year -51,990,000,000
Long Term Debt Past Year 60,502,000,000
Long Term Debt Prior Year 60,527,000,000
Total Debt Most Recent Quarter 60,502,000,000
Equity to Debt Ratio Past Year 0.55
Equity to Debt Ratio Most Recent Quarter 0.55
Total Stockholder Equity Past Year 75,214,000,000
Total Stockholder Equity Prior Year 75,560,000,000
Total Stockholder Equity Most Recent Quarter 75,214,000,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 7,807,000,000
Free Cash Flow Per Share Twelve Trailing Months 6.09
Free Cash Flow Past Year 7,807,000,000
Free Cash Flow Prior Year 6,326,000,000

Options

Put/Call Ratio 0.59
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 0.50
RSI 0.00
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 0.00

System

Modified 4/8/2026 8:56:12 PM EST